Cleerly

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Cleerly, Medical and health, 110 16th Street, Suite 1400 #104, Denver, CO.

Cleerly is a comprehensive, AI-driven platform that quantifies and assesses coronary artery disease (CAD) to deliver clinically actionable insights through a web-based solution. Our software quantifies atherosclerosis by measuring plaque volume, composition, length, and location, evaluates stenosis severity in both 2D (diameter and area) and 3D (lumen and vessel volume), with a workflow for determining the likely presence or absence of ischemia, potentially reducing the need for additional testing and enhancing diagnostic confidence.

07/31/2026

Cleerly sees more of what matters.
That now includes you.

Introducing the Cleerly Patient Site launching today!

More information.
More clarity.
More you.

Helping empower meaningful conversations with your care team. 💪❤️

👉 See what's new: https://patients.cleerly.com?utm_campaign=patient_brand&utm_source=facebook&utm_medium=organic-social&utm_content=patient-website-0731

04/03/2026

📣 NEW key upgrades available now!

Introducing Cleerly® PREVIEW™, an upgrade to our platform built to help care teams prioritize CCTA studies by coronary artery disease severity, supporting faster, more informed clinical decision-making and more efficient workflows.

Key upgrades include:

🔹 Greatest stenosis ranges visible at a glance

🔹 Exact greatest diameter stenosis value and location

🔹 Severity thresholds aligned with common reimbursement considerations

By surfacing these insights earlier in the workflow, PREVIEW enables users to focus attention where it matters most, improve operational efficiency, and support more consistent clinical and administrative decision-making.

👉 Learn more: https://bit.ly/4c5pt5b

02/26/2026

We made the pages of Men's Health! 🙌 Cleerly was featured among new tech shaping the future of data-driven .

Grateful for the recognition and the mission that got us here.

👉 Read the full article: https://bit.ly/40vxV8j

02/12/2026

Not all plaque carries equal risk.

Hard (calcified) plaque is more stable.
Soft (non-calcified) plaque is dangerous.

Soft, non-calcified plaque is more likely to rupture and more likely to be missed by traditional tests.

Cleerly’s advanced plaque analysis color codes and quantifies all types of coronary plaque from a non-invasive CCTA, giving physicians clarity where traditional methods fall short.

With the new Category I CPT® code and increased insurance coverage, our technology is covered for the majority of insured lives across the United States.

👉 Learn more: https://bit.ly/4rg0frg

02/10/2026

Traditional risk models weren’t built for everyone.

is helping change that.

With ~50% female participation across 12 countries, the study has demonstrated that certain coronary plaque features present a higher risk of MACE in women compared to men, emphasizing the need for tailored preventive strategies for women.

More representative data is how we move from one-size-fits-all risk models to truly equitable cardiovascular care. 💪❤️

📝 Source: https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.125.018235

02/06/2026

Team Cleerly is fiRED up to support the American Heart Association's 'Go Red for Women' initiative and bring awareness to heart disease, the #1 killer of women.

On , we’re spotlighting what’s often overlooked:

🟥 Coronary plaque in women

🟥 Underdiagnosis

🟥 Missed risk

When you see more, you can do more. ❤️

Visit goredforwomen.org to learn more!

02/01/2026

❤️ February marks , when the prevention, detection, and care of heart disease steps into the spotlight.

But heart disease isn’t a month-long issue.

According to the CDC, it has remained the leading cause of death in the United States for over 100 years.

While awareness of the most common symptoms and risk factors has improved, heart disease doesn’t always start with symptoms, and physicians' ability to see plaque is the missing piece.

Research shows high-risk soft plaque is the primary driver of disease. However, today’s standard of care often overlooks this silent culprit.

That’s why at Cleerly, Heart Month isn’t just one month; it’s every month.

It’s a philosophy, woven into every conversation and innovation, because creating a new standard of care begins with seeing plaque and understanding risk earlier. 🔍🫀

Source: https://bit.ly/4teVhfU

01/01/2026

✨ Effective today, we're entering a new chapter in heart care coverage.

Cleerly's AI-enabled plaque analysis is now billable under Category I CPT® Code 75577.

Category I designation signals that quantitative plaque assessment is no longer considered experimental; it's a recognized tool that supports doctors in targeting the primary cause of heart disease: plaque buildup in the heart's arteries.

Cleerly helped lead this effort with the American Medical Association over the past five years, and we're excited about what this means for people seeking earlier, clearer answers about their heart health.

Here's to a brighter, healthier 2026! ❤️

12/25/2025

From our hearts to yours, Happy Holidays from team Cleerly!

Wishing you a season full of clarity, connection, and time to focus on what matters most. ❤️

Address

110 16th Street, Suite 1400 #104
Denver, CO
80202

Website

https://patients.cleerly.com/, https://cleerly.com/indications-for-use

Alerts

Be the first to know and let us send you an email when Cleerly posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cleerly:

Want your practice to be the top-listed Clinic in Denver?